ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
6.15
+0.13 (2.16%)
Jun 29, 2026, 2:50 PM EDT - Market open
ImageneBio Employees
ImageneBio had 17 employees as of March 31, 2026. The number of employees increased by 2 or 13.33% since the number was last reported on December 31, 2025.
Employees
17
Change
2
Growth
13.33%
Revenue / Employee
n/a
Profits / Employee
-$3,169,765
Market Cap
69.37M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 17 | 2 | 13.33% |
| Dec 31, 2025 | 15 | 5 | 50.00% |
| Dec 31, 2024 | 10 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| TScan Therapeutics | 139 |
| XBiotech | 87 |
| Acrivon Therapeutics | 76 |
| Seres Therapeutics | 66 |
| PMV Pharmaceuticals | 54 |
| Pliant Therapeutics | 49 |
| BeyondSpring | 44 |
| eXoZymes | 32 |
IMA News
- 18 days ago - Independent Medical Alliance Launches IMA Academy, Expanding Access to Expert-Led, CME-Accredited Medical Education - Business Wire
- 4 weeks ago - ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York - GlobeNewsWire
- 7 weeks ago - ImageneBio price target lowered to $24 from $30 at Leerink - TheFly
- 7 weeks ago - ImageneBio Reports First Quarter 2026 Financial Results and Provides IMG-007 Program Update - GlobeNewsWire
- 7 weeks ago - ImageneBio Quarterly report: Q1 2026 - Filings
- 7 weeks ago - ImageneBio Earnings release: Q1 2026 - Filings
- 2 months ago - ImageneBio Proxy statement: Proxy filing - Filings
- 2 months ago - ImageneBio Proxy statement: Proxy filing - Filings